4/A: Pasithea Therapeutics CEO Corrects Stock Option Exercise Price in Amended SEC Filing
SEC Filing
Tiago Marques, CEO of Pasithea Therapeutics, files an amended Form 4 to correct the exercise price of stock options granted on March 1, 2024.
Summary
- Tiago Marques, the CEO of Pasithea Therapeutics Corp., filed an amended Form 4 with the SEC on April 5, 2024.
- The amendment corrects the exercise price of stock options granted on March 1, 2024, which was previously reported as $8.34 per share but should have been $8.13 per share.
- The corrected exercise price is based on the closing price of Pasithea Therapeutics' common stock on March 1, 2024.
- Marques was granted two stock option awards on March 1, 2024: one for 15,000 shares and another for 11,669 shares, both with an exercise price of $8.13.
- The 15,000 share option vests over three years, while the 11,669 share option was fully vested upon issuance.
- The filing also notes a 1-for-20 reverse stock split that occurred on January 2, 2024, which adjusted the share amounts and exercise prices of outstanding equity awards.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing correcting a minor error. It doesn't contain information that would significantly impact investor sentiment.
Industry Context
Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.
Key Dates
| Date | Description |
|---|---|
| 2024-01-02 | Reverse stock split of 1-for-20 |
| 2024-03-01 | Date of stock option grant and earliest transaction |
| 2024-04-05 | Date of amended Form 4/A filing |
| 2034-02-28 | Expiration date of stock options |
Keywords
Form 4, Pasithea Therapeutics, Stock Options, Tiago Marques, Exercise Price, Amendment, Reverse Stock Split
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.